All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HCV Infection-28489763
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 28489763 C316N
NS5B
NS5B
HCV Infection
D
G
C
L
View
2 28489763 S365A
NS5B
NS5B
HCV Infection
D
G
C
L
View
3 28489763 M414L
NS5B
NS5B
HCV Infection
D
G
C
L
View
4 28489763 M423I
NS5B
NS5B
HCV Infection
D
G
C
L
View
5 28489763 Y448H
NS5B
NS5B
HCV Infection
D
G
C
L
View
6 28489763 I482T
NS5B
NS5B
HCV Infection
D
G
C
L
View
7 28489763 I482V
NS5B
NS5B
HCV Infection
D
G
C
L
View
8 28489763 V494L
NS5B
NS5B
HCV Infection
D
G
C
L
View
9 28489763 P495S
NS5B
NS5B
HCV Infection
D
G
C
L
View
10 28489763 V499A
NS5B
NS5B
HCV Infection
D
G
C
L
View
11 28489763 Q30R
NS5A
NS5A
HCV Infection
D
G
C
L
View
12 28489763 L31M
NS5A
NS5A
HCV Infection
D
G
C
L
View
13 28489763 H58P
NS5A
NS5A
HCV Infection
D
G
C
L
View
14 28489763 A156S
NS3-4A
NS3-4A
HCV Infection
D
G
C
L
View
15 28489763 T54S
NS3-4A
NS3-4A
HCV Infection
D
G
C
L
View
16 28489763 D168Y
NS3-4A
NS3-4A
HCV Infection
D
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.